Dr. Justin Manjourides is a biostatistician and observational health researcher focused on cultivating the next generation of real-world evidence (RWE) researchers. In the last several years, regulators like the US FDA have begun seeking and approving ways to improve drug development efficiency and patient access through real-world evidence, where the use of analyzing how medicines work in the “real world,” physicians can provide, and patients can receive, improved care.  

As an Associate Professor of Biostatistics at Northeastern University’s Bouvé College of Health Sciences, he not only develops curriculum and teaches graduate students focused on medical and public health sciences, but he also serves as the Program Director for their inaugural MS in Real-World Evidence program.  Alongside this work, he co-leads the Data Management and Analytics Cores for a variety of esteemed National Institutes of Health-funded Centers, such as PROTECT and ECHO-PRO. 

Justin is also a co-investigator for the US FDA’s Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) System Program, which aims to develop new and improved ways to access and analyze various surveillance and epidemiologic studies.

Justin’s research is funded through various grants from the US National Institutes of Health, US Environmental Protection Agency, and the US Center for Disease and Prevention, with research ranging from estimating the health effects of environmental exposures and risk mapping of drug-resistant tuberculosis to occupational health and well-being interventions for construction workers.

Justin earned a PhD and an AM in Biostatistics from Harvard University, and a BS in Mathematics and Statistics from the University of Florida.